BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3859399)

  • 1. [Control of cardiac function during therapy with doxorubicin and other anthracyclines].
    Grille W; Johnsen K; Kolenda KD; Schöttler M; Löffler H
    Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1134-7. PubMed ID: 3859399
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of cardiac toxicity of anthracyclines by L-carnitine: preliminary overview of clinical data.
    De Leonardis V; Neri B; Bacalli S; Cinelli P
    Int J Clin Pharmacol Res; 1985; 5(2):137-42. PubMed ID: 3860480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
    Favrot MC; Pouyau G; Souillet G; Philip T; Bozzio A; Philippe N
    Pediatrie; 1981 Sep; 36(6):437-50. PubMed ID: 6947199
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy-induced cardiac toxicity and management].
    Komagata H; Sakai H
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):787-92. PubMed ID: 12852345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial imaging with Tc-99m pyrophosphate in patients with adriamycin for neoplasia.
    Soin JS
    J Nucl Med; 1978 May; 19(5):564-5. PubMed ID: 205637
    [No Abstract]   [Full Text] [Related]  

  • 6. Noninvasive cardiac evaluation of patients receiving adriamycin.
    Ewy GA; Jones SE; Friedman MJ; Gaines J; Cruze D
    Cancer Treat Rep; 1978 Jun; 62(6):915-22. PubMed ID: 667868
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiotoxicity of doxorubicin and other anthracycline derivatives.
    Jain D
    J Nucl Cardiol; 2000; 7(1):53-62. PubMed ID: 10698235
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heart diseases caused by cytostatic agents].
    González Larriba JL
    Rev Clin Esp; 2001 Feb; 201(2):90-2. PubMed ID: 11345613
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocardial imaging with Cc-99m pyrophosphate in patients on adriamycin treatment for neoplasia.
    Chacko AK; Gordon DH; Bennett JM; O'Mara RE; Wilson GA
    J Nucl Med; 1977 Jul; 18(7):680-3. PubMed ID: 194931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anthracycline cardiotoxicity: review].
    Ribera JM; Montserrat E; Rozman C
    Sangre (Barc); 1983; 28(1):54-68. PubMed ID: 6346540
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiotoxicity of antitumor agents.
    Kantrowitz NE; Bristow MR
    Prog Cardiovasc Dis; 1984; 27(3):195-200. PubMed ID: 6387802
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monitoring of cardiac function in anthracycline therapy in childhood].
    Jensen E; Richter R; Mittler U; Kluba U; Aumann V
    Padiatr Grenzgeb; 1984; 23(6):455-65. PubMed ID: 6598219
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased risk of cardiac dysfunction after anthracyclines in girls.
    Silber JH; Jakacki RI; Larsen RL; Goldwein JW; Barber G
    Med Pediatr Oncol; 1993; 21(7):477-9. PubMed ID: 8341214
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiotoxicity of anthracyclines.
    Green MD; Speyer JL; Muggia FM
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):293-6. PubMed ID: 6584310
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiotoxicity of anthracyclines].
    Ferrière M; Donadio D; Ramirez R
    Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():53-8. PubMed ID: 8215791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?
    Theodoulou M; Hudis C
    Cancer; 2004 May; 100(10):2052-63. PubMed ID: 15139046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of cardiotoxic effects of anthracyclines in oncopediatric praxis].
    Safonova SA; Gershanovich ML; Punanov IuA
    Vopr Onkol; 2006; 52(5):590-2. PubMed ID: 17168373
    [No Abstract]   [Full Text] [Related]  

  • 18. Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin).
    Machado V; Cabral A; Monteiro P; Gonçalves L; Providência LA
    Rev Port Cardiol; 2008 Oct; 27(10):1277-96. PubMed ID: 19178029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection.
    Mortensen SA; Aabo K; Jonsson T; Baandrup U
    Int J Clin Pharmacol Res; 1986; 6(2):137-50. PubMed ID: 3459718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization.
    Bristow MR; Mason JW; Billingham ME; Daniels JR
    Ann Intern Med; 1978 Feb; 88(2):168-75. PubMed ID: 626445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.